Genetic Technologies Has Been Granted Canadian Patent Number 2962691 Titled "Methods For Assessing Risk Of Developing Breast Cancer"
Portfolio Pulse from Benzinga Newsdesk
Genetic Technologies has been granted Canadian Patent Number 2962691 for its methods of assessing the risk of developing breast cancer. This patent could potentially expand the company's market reach.
May 23, 2023 | 6:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Genetic Technologies' granted patent for breast cancer risk assessment methods may lead to market expansion and increased revenues.
The granted patent directly pertains to Genetic Technologies' product offerings and could potentially expand the company's market reach. This may lead to increased revenues and a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100